1. Market Research
  2. > Pathology
29 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

2024 Sweden Hematology and Flow Cytometry Analyzers and Reagents Market: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation and Opportunities

  • $ 1450
  • July 2020
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Sweden
  • Demand

Sweden Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 750
  • September 2019
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Sweden
  • Demand

Sweden Hematology and Flow Cytometry Analyzers and Reagents Market, 2019-2023: Supplier Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 750
  • June 2019
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Biopharmaceutical
  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Sweden

Europe Pediatric Proton Therapy Market & Forecast (6 Countries Market Data), Patients Treated, Reimbursement Policies

  • $ 1600
  • July 2017
  • 108 pages

For sarcomas and lymphomas, proton therapy may also deliver less radiation to the heart, lungs, and intestines.

  • Cancer
  • Lymphoma
  • Sweden
  • Hitachi, Ltd.
  • Mitsubishi Corporation

Europe Proton Therapy Market & Forecast, Patients Treated at Proton Therapy Centers, Reimbursement Policy

  • $ 1700
  • April 2017
  • 138 pages

The patient population will consist of pediatrics, adolescents, and young adults with cancers, such as Brain Tumors, Rhabdomyosarcomas, and Lymphomas.

  • Hospital
  • Lymphoma
  • Sweden
  • Market Size
  • Varian Medical Systems, Inc.

Sweden Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022

  • $ 1050
  • May 2017
  • 52 pages

The patient population will consist of pediatrics, adolescents, and young adults with cancers, such as Brain Tumors, Rhabdomyosarcomas, and Lymphomas.

  • Cancer
  • Diagnostic Imaging
  • Lymphoma
  • Specialty Hospital
  • Sweden

IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Sweden

  • $ 1700
  • December 2016
  • 43 pages

SWE EN CANADA IMS Pharmaceutical Pricing & Reimbursement Concise Guide Published December 2014 Published September 2014 The Information Service contained herein is confidential and provided subject to the IMS Health Information Services Standard Terms and Conditions.

  • Hospital
  • Lymphoma
  • Pharmaceutical
  • Pharmacy
  • Sweden

Medivir AB (MVIR B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 50 pages

We reported topline data from the phase II study of remetinostat in CTCL (cutaneous Tcell lymphoma) after the end of the reporting period.

  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • Sweden
  • Medivir UK Ltd.

Kancera AB (KAN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 27 pages

In lymphoma (blood cancer), several research groups have reported that the fractalkine system is activated and correlated to rapid disease development.

  • Cancer
  • Lymphoma
  • Pharmaceutical
  • Sweden
  • Kancera Group

Asarina Pharma AB (ASAP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 21 pages

Summary Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB, is a sepranolone product developer.The company offers discovery, development and commercialization of ...

  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • Sweden
  • Company

Oasmia Pharmaceutical AB (OASM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 52 pages

Doxophos Vet has been granted MUMS designation (see below) in the US for the indication lymphoma.

  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • Sweden
  • Oasmia Pharmaceutical AB

Cadila Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 26 pages

The company offers products such as VAL-##, which is used in the treatment of diffuse large B-cell lymphoma; RESP- ## and RESP-2000 series, used for the treatment of COPD and asthma; and RESP-##, a biomarker used for cardiovascular PET-imaging.

  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • Sweden
  • Cadila Healthcare Ltd

Asarina Pharma AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • August 2018
  • 19 pages

Summary Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB, is a sepranolone product developer.The company offers discovery, development and commercialization of ...

  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • Sweden
  • Company

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 53 pages

Its pipeline for animal health includes paccal vet (paklitaxel) and doxophos vet (doxorubicin), currently under phase ## stage, intended for the treatment of mastocytoma and lymphoma, respectively.

  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • Sweden
  • Weifa

A1M Pharma AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 30 pages

It conducts research on various diseases such as cervical cancer, colorectal cancer, crohn' s disease, cystic fibrosis, esophageal cancer, influenza, kaposi sarcoma, barrett' s esophagus, brain tumors, breast cancer, leukemia, lung cancer, lymphoma, malaria, melanoma, sickle cell di

  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • Sweden

Respiratorius AB (RESP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • December 2018
  • 18 pages

Valcuria owns the rights to cancer project VAL-##, a project that has clear positive experimental evidence against large B-cell lymphoma.

  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • Sweden
  • Cadila Healthcare Ltd

Inhalation Sciences Sweden AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • September 2018
  • 25 pages

Summary Inhalation Sciences Sweden AB (ISAB) develops and sells innovative laboratory equipment for inhalation research and provides drug development services.The company’s product portfolio includes ...

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Sweden

Karolinska Development AB (KDEV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 67 pages

Summary Karolinska Development AB (Karolinska Development) is a life sciences investment company that develops innovations from science into commercial products.The company invests in start up’s and ...

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Sweden
  • Company

Affibody AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 22 pages

Pharmaceuticals & Healthcare - Deals and Alliances Profile Affibody AB Report Code: GDPH##D Published: November 2018 Affibody AB (Affibody) is a biotech company that discovers and develops next generation biopharmaceuticals and related drugs.

  • Lymphoma
  • Medical Biotechnology
  • Pharmaceutical
  • Sweden
  • Affibody AB

Immunovia AB (IMMNOV) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 43 pages

The institute' s target therapy areas include leukemia, lymphoma, blood cancer, lung cancer, breast cancer, colorectal cancer and skin cancer, among others.

  • Autoimmune Disease
  • Cancer
  • Lymphoma
  • Pancreatic Cancer
  • Sweden
View report >

Cancer Statistics

  • August 2019
  • 56 pages

Patients diagnosed 2000 to 2016 were identified in the National Swedish Lymphoma Register.

  • Cancer
  • Hospital
  • Lymphoma
  • Pathology
  • Sweden

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on